Dr Geoffrey Ginsburg is the founding director for the Centre for Applied Genomics and Precision Medicine at the Duke University Medical Centre and for MEDx, a partnership between the Schools of Medicine and Engineering to spark and translate innovation. His research addresses the challenges for translating genomic and digital information into medical practice and the integration of precision medicine into healthcare.
In 2017, he received Duke’s Translational Research Mentorship Award and is a finalist in the NIH/BARDA Antimicrobial Resistance Prize. He is a member of the Advisory Council to the Director of NIH and is co-chair of the National Academies Roundtable on Genomic and Precision Health. He is founder and president of the Global Genomic Medicine Collaborative, a not-for-profit organisation aimed at creating international partnerships to advance the implementation of precision medicine.
He has recently served as a member of the Board of External Experts for the NHLBI, the advisory council for the National Centre for Accelerating Translational Science, the chair of the review for Genome Canada’s Large Scale Applied Research Competition in Genomics and Precision Medicine, and the World Economic Forum’s Global Agenda Council on the Future of the Health Sector.
Dr Ginsburg is also the founder of Predigen Inc and MeTree and You Inc. He was previously Vice President of Molecular Medicine at Millennium Pharmaceuticals, Inc and a faculty member at Harvard Medical School.
